Q4 Results: Profit aur Revenue dono down!
Asal mein, company ka Net Profit 84% gir kar sirf ₹20 Crore reh gaya hai, jo pichhle saal isi quarter mein ₹120.4 Crore tha. Revenue bhi 26.3% neeche aaya hai, ab ₹619.1 Crore ho gaya hai.
EBITDA aur Margins par bhi pressure
Sirf profit hi nahi, EBITDA bhi 60% ho gaya kam, matlab ₹98.7 Crore pe aa gaya, jo pehle ₹229.2 Crore tha. Iski wajah se company ke operating margins bhi kaafi tight ho gaye hain, 15.9% pe aa gaye hain jo pehle 27.3% the.
Aage kya? FY27 mein recovery ki umeed
Ab sawaal aata hai ki aage kya? Company ka kehna hai ki FY27 ke second half mein growth phir se start ho sakti hai. Unhone saaf bola hai ki FY27 ka pehla quarter sabse mushkil rahega, revenue aur EBITDA dono ke liye.
Recovery drivers aur strong pipeline
Yeh recovery kahan se aayegi? Company ko apne current projects, naye customers aur manufacturing platforms ke better use se umeed hai. Aur haan, in sab challenges ke beech bhi, unka pipeline kaafi solid dikh raha hai. Small molecules, ADCs, aur complex chemistries ke liye proposals aa rahe hain. Ab bas bade projects mein win rates improve karne par focus hai.
